Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
71 hedge funds and large institutions have $40.9M invested in Ampio Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 8 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
60% more call options, than puts
Call options by funds: $4.01M | Put options by funds: $2.51M
29% more funds holding
Funds holding: 55 → 71 (+16)
16% more capital invested
Capital invested by funds: $35.3M → $40.9M (+$5.54M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.68M |
| 2 |
Millennium Management
New York
|
+$1.67M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.24M |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$869K |
| 5 |
Goldman Sachs
New York
|
+$780K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$714K |
| 2 |
VF
Virtu Financial
New York
|
-$376K |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
-$204K |
| 4 |
NFG
Noven Financial Group
Denver,
Colorado
|
-$151K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$149K |
AMPE Hedge Fund Activity: Q1 2018 in Review
71 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2018, worth a combined $40.9M — up 16% from $35.3M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new AMPE positions and 8 closed out — a net gain of 16 holders — while 20 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.68M. The largest seller was Group One Trading, cutting an estimated $714K.
- 71 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2018, up from 55 in Q4 2017.
- Funds reported $40.9M of Ampio Pharmaceuticals Inc. stock for Q1 2018, up 16% quarter-over-quarter.
- 24 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2018 and 8 closed out, a net change of +16 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2018 was Vanguard Group, an estimated $1.68M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2018 was Group One Trading, an estimated $714K sold.
Based on aggregated 13F filings for Q1 2018.